Eli Lilly and Company is donating COVID-19 therapies to Direct Relief, enabling the humanitarian organization to provide COVID-19 therapies at no cost to low- and lower-middle-income countries most heavily impacted by the pandemic. This donation furthers both Lilly and Direct Relief’s charitable goal of providing access to COVID-19 treatments to patients in need by providing […]

The post Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countries first appeared on World Pharma Today.